Apellis Pharmaceuticals (APLS) files automatic mixed securities shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
Apellis Pharmaceuticals (APLS) Prices 9.5M Share Offering at $37/Sh
January 9, 2020 5:55 AM ESTApellis Pharmaceuticals, Inc. (NASDAQ: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced the pricing of its underwritten public offering of 9.5 million shares of its common stock at a public offering price of $37.00 per share, for total gross proceeds of $351.5 million, before deducting... More
Apellis Pharmaceuticals (APLS) Announces Proposed 7M Share Common Offering
January 7, 2020 4:13 PM ESTApellis Pharmaceuticals, Inc. (NASDAQ: APLS) today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock. All of the shares are being offered by Apellis. In addition, Apellis expects to grant the underwriters a 30-day option to... More

